PELLEGRITI, GABRIELLA
 Distribuzione geografica
Continente #
NA - Nord America 5.084
EU - Europa 2.810
AS - Asia 2.799
AF - Africa 396
SA - Sud America 375
Continente sconosciuto - Info sul continente non disponibili 154
OC - Oceania 5
Totale 11.623
Nazione #
US - Stati Uniti d'America 4.876
SG - Singapore 1.217
RU - Federazione Russa 922
CN - Cina 860
IT - Italia 705
BR - Brasile 296
IE - Irlanda 257
CI - Costa d'Avorio 247
VN - Vietnam 218
UA - Ucraina 212
KR - Corea 187
DE - Germania 143
CA - Canada 140
FR - Francia 133
SE - Svezia 127
GB - Regno Unito 88
BD - Bangladesh 84
IN - India 64
NG - Nigeria 55
NL - Olanda 43
FI - Finlandia 40
MX - Messico 34
SN - Senegal 30
AR - Argentina 26
PL - Polonia 25
JP - Giappone 24
ES - Italia 23
ZA - Sudafrica 22
HK - Hong Kong 21
CO - Colombia 17
TR - Turchia 17
BJ - Benin 16
CZ - Repubblica Ceca 16
IQ - Iraq 16
ID - Indonesia 14
CH - Svizzera 10
LT - Lituania 10
UZ - Uzbekistan 10
CL - Cile 9
MY - Malesia 9
PK - Pakistan 9
VE - Venezuela 9
TT - Trinidad e Tobago 8
AT - Austria 7
AZ - Azerbaigian 6
BE - Belgio 6
JM - Giamaica 6
LB - Libano 6
PY - Paraguay 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
EC - Ecuador 5
MA - Marocco 5
RO - Romania 5
RS - Serbia 5
AL - Albania 4
BO - Bolivia 4
CR - Costa Rica 4
IR - Iran 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
PH - Filippine 4
AU - Australia 3
EG - Egitto 3
GR - Grecia 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
SI - Slovenia 3
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
LV - Lettonia 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
Totale 11.461
Città #
Singapore 774
Dallas 636
Santa Clara 612
San Jose 486
Chandler 406
Moscow 403
Hefei 262
Dublin 257
Abidjan 247
Ashburn 243
Chicago 227
Jacksonville 195
Houston 188
Seoul 187
Los Angeles 171
Beijing 139
Boardman 139
Council Bluffs 128
Lauterbourg 95
Catania 93
Civitanova Marche 89
Grafing 76
Ho Chi Minh City 74
Cambridge 69
Andover 67
Lawrence 67
Nanjing 67
Toronto 66
New York 62
Buffalo 60
Hanoi 44
Wilmington 40
Rome 38
Montreal 36
São Paulo 34
Orem 31
Dakar 30
Des Moines 30
San Mateo 30
Lagos 29
Nanchang 26
Brooklyn 25
Abuja 24
Munich 24
Tokyo 24
Palermo 23
The Dalles 22
Hebei 21
Pescara 21
Saint Petersburg 21
Bari 20
Columbus 20
Hong Kong 20
Ottawa 20
Chennai 18
Johannesburg 18
Warsaw 18
Amsterdam 17
Helsinki 17
Shenyang 17
Stockholm 17
Cotonou 16
London 16
Kochi 15
Milan 15
Seattle 15
Bremen 14
Messina 14
Phoenix 14
Atlanta 13
Poplar 13
Rio de Janeiro 13
Boston 12
Brno 12
Changsha 12
Lappeenranta 12
Mexico City 12
Misterbianco 12
Da Nang 11
Frankfurt am Main 11
Marseille 11
Quintano 11
Denver 10
Querétaro 10
San Francisco 10
Turku 10
Amantea 9
Dearborn 9
Dong Ket 9
Haiphong 9
Aci Castello 8
Chieti 8
Iserlohn 8
Jiaxing 8
Naples 8
Norwalk 8
Woodbridge 8
Baghdad 7
Charlotte 7
Manchester 7
Totale 7.787
Nome #
Time to Separate Persistent from Recurrent Differentiated Thyroid Cancer: Different Conditions with Different Outcomes 295
Chemioterapia con fluorouracile (FU) in infusione continua e vinorelbina (VNB) nel carcinoma differenziato della tiroide (CDT) in fase avanzata 196
Absorbed Dose Evaluation in Radioiodine Therapy with Different Approaches 188
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 185
Thyroidectomy as Treatment of Choice for Differentiated Thyroid Cancer 179
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 172
Outcome of the Diffuse Sclerosing Variant of Papillary Thyroid Cancer: A Meta-Analysis 163
BRAF(V600E) mutation and the biology of papillary thyroid cancer 160
Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors 159
L’ipertiroidismo è un fattore di rischio di trombosi venosa e arteriosa: descrizione di un caso clinico 150
A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma 150
[Differentiated carcinoma of the thyroid in the young. Clinical and histopathologic aspects] 149
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases 147
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 146
Lymph node location is a risk factor for papillary thyroid cancer-related death 143
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 143
Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution 142
Risk of benign and malignant thyroid disorders in subjects treated for paediatric/adolescent neoplasia: Role of morphological and functional screening 141
Editorial: Clinical and molecular epidemiology of thyroid cancer of follicular origin 140
Differentiated thyroid cancer in children and adolescents 139
Increased mortality in patients with differentiated thyroid cancer associated with graves' disease 138
Persistenza vs Recidiva di malattia nel Carcinoma Differenziato della Tiroide 138
Caratteristiche istologiche e cliniche della variante sclerosante diffusa del carcinoma papillifero tiroideo 137
Heavy Metals in the Environment and Thyroid Cancer 135
Caratteristiche istologiche alla diagnosi e decorso clinico in pazienti tiroidectomizzati per carcinoma papillare variante sclerosante diffusa: studio di metanalisi 134
Orbital metastasis from thyroid cancer: a case report and review of the literature 133
Caratteristiche cliniche e istologiche di una serie di 23 pazienti affetti da carcinoma tiroideo della cisti del dotto tireoglosso 133
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome 130
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 128
Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods 127
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 124
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 123
Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review 121
Is multifocality a risk factor in low-risk papillary thyroid cancer? 119
Long-term outcome of patients with insular carcinoma of the thyroid 117
Prognostic factors for adrenocortical carcinoma outcomes 116
Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study 116
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 115
Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy 115
Outcome of differentiated thyroid cancer in Graves' patients 113
Soggetti trattati con chemio e/o radioterapia in età pediatrica per neoplasia: patologia tiroidea (morfo-funzione) 112
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 110
Farmaci innovativi per il trattamento del carcinoma tiroideo avanzato 110
Evidenza RMN di metastasi orbitaria da carcinoma papillifero tiroideo avanzato: rara osservazione successiva a remota chemio- e radioterapia per Linfoma non Hodgkin 110
Giant parathyroid adenoma: a rare cause of primary hyperparathyroidism mimicking a carcinoma 110
Descriptive epidemiology of human thyroid cancer: Experience from a regional registry and the "volcanic factor" 110
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 109
EP-1773 Radioiodine therapy: a dosimetric study in a patient with DTC after rhTSH stimulation 108
Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol 107
Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: A retrospective analysis of 74 families 105
Response to Letter to the Editor: "Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes" 105
Therapeutic Efficacy of a Very Low/Low Dose of Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer: A Real-World Series from a Single Center 103
Thyroid cancer in thyroglossal duct cysts requires a specific approach due to its unpredictable extension. 103
Gestione del carcinoma tiroideo in età pediatrica [Management of thyroid carcinoma in the paediatric age] 102
Several site-specific cancers are increased in the volcanic area in Sicily 102
Papillary thyroid cancer incidence in the volcanic area of Sicily 102
Chemotherapy with continous infusion of fluorouracil (FU) and vinorelbine (VNB) in advanced differentiated thyroid cancer (DTC) 101
Ruolo della 18FDG PET nel follow-up del carcinoma differenziato della tiroide (CDT) in presenza di valori di Tireoglobulina (Tg) indosabili, AAT elevati e TBS post-131-I negativo: esperienza clinica in una paziente 100
Role of gender on adverse events in a consecutive series of 28 patients with advanced differentiated thyroid cancer receiving lenvatinib 100
Antioxidant Defense Capacity Is Reduced in Thyroid Stem/Precursor Cells Compared to Differentiated Thyrocytes 100
Cardiac arrest after intravenous calcium administration for calcitonin stimulation test 100
Thyroid cancer in thyroglossal dust cyst requires a specific approach due to its unpredictable extension. 100
Prospective study and proposal of an outcome predictive nomogram in a consecutive prospective series of differentiated thyroid cancer based on the new ATA risk categories and TNM 95
Ruolo prognostico dello status linfonodale alla diagnosi sull’evoluzione clinica di 4292 pazienti tiroidectomizzati per carcinoma differenziato della tiroide (CDT) 92
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 92
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 91
Risk-stratified evaluation of over 16000 thyroid microcarcinomas: at presentation more than one third have two or more risk factors for recurrence. 91
The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels 90
Long-term outcome of medullary thyroid carcinoma in patients with normal postoperative medical imaging 89
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 88
The new AJCC/TNM Staging System (VIII ed.) in papillary thyroid cancer: clinical and molecular impact on overall and recurrence free survival 87
Mortality of differentiated thyroid cancer in Graves’s patients. 87
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer 86
Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment 85
Utilità del dosaggio ultrasensibile della tireoglobulina per il follow-up dei pazienti con carcinoma tiroideo differenziato classificati per livello di rischio di recidiva. 83
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer 82
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients 82
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 82
The BRAF(V600E) mutation influences the short- and medium-term outcomes of classic papillary thyroid cancer, but is not an independent predictor of unfavorable outcome. 81
Metastatic malignant struma ovarii with coexistence of Hashimoto’s thyroiditis 80
TSH ricombinante umano nei pazienti con carcinoma tiroideo differenziato: utilità del follow-up a breve e a lungo termine 80
Valore predittivo del dosaggio della tireoglobulina sierica alla prima valutazione post-tiroidectomia nei pazienti con carcinoma papillifero della tiroide di piccole dimensioni 78
Prognostic significance of serum Tg in differentiated thyroid cancer (DTC) patients before 131-I ablation and its correlation with neck 131-I uptake. 78
Thyroglobulin measurements after rhTSH stimulation in the follow-up of patients with differentiated thyroid cancer 77
Occurrence of distant metastates as the first sign of disease is a strong prognostic factor of poor outcome in patients with differentiated thyroid cancer 74
Pancreatic Neuroendocrine Tumors: Experience from a Single Institute 73
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin. 72
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: A 2015 position statement of the Italian Society of Endocrinology 71
Update on thyroid cancer treatment 71
Thyroid Tumor Registry of Sicily: Molecular Epidemiology 70
Usefulness of rhTSH in the management of differentiated thyroid cancer 70
Proposta di modifica della stadiazione TNM dei pazienti con carcinoma tiroideo a bass rischio (stadio I). 70
Gender Impact on Safety and Efficacy in Lenvatinib treated patients with radioiodine-refractory Differentiated Thyroid Cancer (GISEL study) 70
Response: Re: Papillary thyroid cancer incidence in the volcanic area of sicily 67
Predictive factors of persistent disease in a large cohort of pediatric patients with differentiated thyroid carcinoma 67
False positive 131I total body scan due to bilateral polycystic renal disease 67
Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine 67
The influence of the environment on the development of thyroid tumors: A new appraisal 64
Usefulness of recombinant human TSH (rhTSH) in the radiometabolic treatment of selected thyroid cancer patients 62
Neuroendocrine tumors and Von Hipple-Lindau disease: Three cases [Tumeurs neuro-endocrines et maladie de Von Hippel-Lindau: 3 Observations] 61
Totale 11.080
Categoria #
all - tutte 37.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.781


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 0 0 3 12 71 2 73 17 46 0 15 115
2022/20231.056 71 67 16 135 98 153 19 193 235 8 32 29
2023/2024671 30 94 20 33 23 166 0 76 9 15 74 131
2024/20252.323 26 372 162 144 470 295 67 69 119 181 198 220
2025/20265.595 345 472 771 335 819 1.105 616 86 386 301 211 148
2026/2027325 85 227 13 0 0 0 0 0 0 0 0 0
Totale 11.623